B2DB — Who said what, where, and when

Engineering Cyclotides as Orally Bioavailable Inflammatory Cytokine Antagonists

Tides 2027 · 28 April 2027 · 10:45–11:15

Engineering Cyclotides as Orally Bioavailable Inflammatory Cytokine Antagonists was a session at Tides 2027 on 28 April 2027 in Boston.